UK: PRIME Workshop 2: The Similarities and Distinctions between Long Covid & ME/CFS, 24th April, 2026 2-5pm GMT

I listened to this.
Nothing very new I am afraid.

Danny Altman did not give any detail about Rosetta Stone plans - which look rather like a re-rumn of what has been done for ME/CFS over the last decade. He mentioned that rates of diagnosis of autoimmune disease like RA and lupus were about 3 times higher after Covid I think. I wonder if that tells us much with all the issue about ascertainment. What I don't think it tells us about is Long Covid, since LC is not RA or lupus but LC.

The Precision Life presentation seemed to be what we are familiar with. They seem to be leaping from genetic clues to treatment strategies rather too quickly for my liking but we have discussed that before.

Amy Proal seemed to be giving the standard 'ME/CFS specialist' folklore about every infection under the sun possiby being dormant and causing ME/CFS. She did make the point that symptoms seem to point to brain stem or thereabouts. I would put it more in hypothalamus but not so far away. She drew on a lot of very old data that we have been sceptical about.

Manoj Sivan talked about diagnostic criteria and PROMS for reasons that I was not clear. He claims that you do not need a controlled trial to tell if your treatment strategy works - just a consensus. I do wish people would raise the game a bit on that. He also mentioned that people 'on forums' had been complaining about treatment being under rehab! (In fact Caroline Dalton raise this and he took the opportunity to rebut the suggestion that you could do without rehab for anything.) To be fair, he agreed that it might be good for ME/CFS to be under a speciality so that clinical care could be linked in to research.

Nisreen Alwan was quite interesting on stigma and the need for a more sophisticated approach to diagnostic categorisation but there wasn't anything very new.
 
@Andy, is there a recording available?

What was the rationale for inviting Amy Proal (viral persistence) and Manoj Sivan (all healthcare is rehab https://www.s4me.info/threads/an-op...uide-to-therapy-2025.48904/page-4#post-675448)?
From AfME's website (which I don't think has a recording for the PRIME Workshop 1 held in January yet), the aim of PRIME is:
... to bring together researchers from a range of backgrounds, and private sector/industry partners to investigate the genetics, biomarkers and disease mechanisms of ME/CFS and to identify a pathway towards effective treatments.
PRIME stands for “Building Infrastructure for Patients, Researchers and Industry for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.”
It is an initiative designed to strengthen and accelerate research into ME/CFS. Funded by the UK Medical Research Council from 2025–2029, PRIME is led by the University of Edinburgh in partnership with Action for ME and aims to:

· Catalyse 15 new research collaborations
· Develop two international research consortia
· Establish a Public and Patient Involvement Pool to support meaningful collaboration with people with lived experience in research

Building research infrastructure is a laudable aim, but I feel a bit uneasy that PRIME may be reaching out to a whole lot of people who probably should not be platformed. I hope it will not be a tick box exercise of 'catalysing 15 new research collaborations' with researchers close to hand, already in the ME/CFS and LC spaces, eager for any platform and possibly doing work that is counterproductive. The aim of 15 research collaborations is all very good, but if they are going to just be the same people saying the same things, it won't get us very far. For example, from what @Jonathan Edwards says about Manoj Sivan's presentation and what we know about him already, it will be a shame if he is part of any PRIME collaborations and planned international research consortia.

Manoj Sivan talked about diagnostic criteria and PROMS for reasons that I was not clear. He claims that you do not need a controlled trial to tell if your treatment strategy works - just a consensus.
I listened to this.
Nothing very new I am afraid.
With a workshop topic that seemed to fundamentally misunderstand the nature of the Long COVID label, seeing Long Covid as a single disease (see my post on that upthread) and some odd choices of presenters, things are looking a little concerning. It's early days of course. I really hope that scarce funding will not be frittered away on more of the usual people saying the usual things. As a person with ME/CFS wanting answers, I value quality over quantity.
 
The whole framing sounds very muddled and disappointing. As long as long covid is treated like some mystical illness and not an umbrella term for all sorts of things happening after COVID I don’t think we’ll be able to make much advancement. Even RECOVER seems to have somewhat learned from their lessons and is subtyping now.
 
As long as long covid is treated like some mystical illness...

I agree. As long as these are treated as mystery diseases that need diagnostic biomarkers so that you can put them in convenient pigeonholes progress will be minimal. I think Alwan appreciated that but she is not going to work out the pathomechanics. The Precision Life approach tries to get there but their sales pitch on personalised therapies is hard to believe in.
 
For example, from what @Jonathan Edwards says about Manoj Sivan's presentation and what we know about him already, it will be a shame if he is part of any PRIME collaborations and plan
Agreed, it will be beyond disappointing if the rehab people manage to coopt this project. Everything they are involved with they attempt to bend to their own ends.
 
Agreed, it will be beyond disappointing if the rehab people manage to coopt this project. Everything they are involved with they attempt to bend to their own ends.
Sometimes, when you're really unlucky, you can get both the pan and the fire. And sometimes there's also someone back there turning up the heat all the way to max.

We are that unlucky. It's just astounding how badly we are failed, it rivals what one would expect out of a corrupt nepotistic decaying aristocracy, one that would actually manage to suggest getting out the violins to distract from all the burning and looting.
 
Government: We need to make these sick people healthier.

Rehabbers: We can make them healthier.

Government: How?

Rehabbers: Healthier people do more and report that they feel better. We’ll instruct the sick people to do more and reassure them that they should feel better.

Government: Great! Here’s a blank cheque. Continue until their health improves.
 
Also:

Government: We need to get sick people back to work.

Rehabbers: We can stop them believing they're sick.

Government: How?

Rehabbers: We tell them they're not sick and get them to spend every day answering questions on apps. Then you've got proof they do admin every day, and can find them fit for work.

Government: Great! Here’s a blank cheque.
 
General abstract:

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-acute sequelae of SARS-CoV-2 infection (Long Covid) are complex, multisystem conditions with substantial symptom overlap and marked functional impairment. Epidemiological studies indicate that approximately two-thirds of individuals with ME/CFS report a preceding acute infection, most commonly viral, prior to symptom onset. Long Covid is defined by the persistence or emergence of symptoms for at least 12 weeks following acute SARS-CoV-2 infection, providing a clearly identified infectious trigger. Both conditions share core clinical features, including post-exertional malaise, disabling fatigue, cognitive dysfunction, sleep disturbance, autonomic symptoms, and pain, suggesting overlapping pathophysiological pathways.

Important distinctions between the two diseases remain. ME/CFS is a heterogeneous syndrome that can follow non-infectious triggers, whereas Long Covid is, by definition, post-viral. In addition, certain symptoms, such as anosmia and prominent respiratory complaints, are more prevalent in Long Covid, particularly early in the disease course.

This workshop will critically examine similarities and distinctions between ME/CFS and Long Covid across clinical, biological, and research frameworks, with the aim of leveraging insights from both fields to inform diagnosis, stratification, and therapeutic development.

Speakers:
  • Prof. Danny Altmann – Professor of Immunology, Imperial College Faculty of Medicine
    Rosetta Stone - a new study funded by the ME Association to characterise shared pathways between ME/CFS and Long Covid

  • Dr. Andy Malinowski – VP Disease Biology, PrecisionLife
    Genetic Commonalities between ME/CFS and Long COVID: Insights from Combinatorial Analysis

  • Dr. Amy Proal – CEO/Research Director, PolyBio Research Foundation
    Long COVID and ME/CFS: why persistent infections matter

  • Prof. Manoj Sivan – Professor & Honorary Consultant in Physical & Rehabilitation Medicine, Univ. Leeds
    The overlapping clinical syndromes of Long COVID and ME/CFS

  • Prof. Nisreen Alwan – Head of the Centre for Population Health Sciences and Professor of Public Health at the University of Southampton
    What is the role of the 'case definition' in shaping the research and health inequalities landscapes of ME/CFS and Long Covid?
Online: Register here
I’m trying to keep up and not read more than above , but when describing the ‘important distinctions’ I was under the impression that PEM being required and the tighter definition theoretically makes me/cfs more ‘specific’/ less heterogenous vs long covid which can be ‘anything post-covid’ and includes eg the lung or heart issues.

And the length of time people have had it for is another issue. Unless something has changed recently actually on the ground most with me/cfs have it a long time before getting it on their papers do to speak whereas due to the nature of being signed off work and having clinics for it LC was 4-6weeks wasn’t it ?

There is a very significant difference between noting ‘some have PEM’ (and it not being as defined so is it PEM) and me/cfs and where things should be every time someone defines and describes it to ensure it isn’t being put across as if it’s just some fatigue+persistent symptoms melee - which would be taking ourselves backwards to what needed to be broken away from

Eg the days where people got diagnosed with fibro or cfs depending on what the physician tended to prefer of the two not their constellation of main symptoms fitting one or the other and burying us as just chronically fatigued ill people who have lots of different symptoms instead of focusing on the key pattern that joins the group together as a proper defined condition.

I’m not happy with this describing above for this context to be frank
 
Back
Top Bottom